ReviewJournal of epidemiology2013
High-density lipoprotein and prostate cancer: an overview.
Review in Journal of epidemiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06860425 (Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity), which is not on this map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
Who cites it
34 citing papers in PubMed, 54 citations in OpenAlex.
- Cholesterol in hematological malignancies: metabolism, mechanisms, and clinical implications.Frontiers in immunology · 2026Review
- Association between high‑density lipoproteins and prostate specific antigen: A cross‑sectional study from NHANES database.Molecular and clinical oncology · 2025Article
- Study of the interaction between cardiometabolic index and inflammatory index on the risk of prostate cancer development.Frontiers in immunology · 2025Article
- Article
- Association between low density lipoprotein cholesterol levels and prostate cancer risk in non-hypertensive middle-aged and older American men.Scientific reports · 2024Article
- Total-, LDL-, and HDL-cholesterol, apolipoproteins, and triglycerides with risk of total and fatal prostate cancer in Black and White men in the ARIC study.The Prostate · 2023Article
- Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia.International journal of molecular sciences · 2023Article
- Article
- Inflammatory metabolic profile of South African patients with prostate cancer.Cancer & metabolism · 2021Article
- The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.BMC cardiovascular disorders · 2020Article
- Low level of serum high-density lipoprotein cholesterol in gastric cancer correlates with cancer progression but not survival.Translational cancer research · 2020Article
- Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.Cancer causes & control : CCC · 2020Article
- Correlation between immune signature and high-density lipoprotein cholesterol level in stage II/III colorectal cancer.Cancer medicine · 2019Article
- Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.Prostate cancer and prostatic diseases · 2019Article
- Article
- The predictive value of high-density lipoprotein for ocular metastases in colorectal cancer patients.Cancer management and research · 2019Article
- Relationship between Inflammatory and Biological Markers and Lung Cancer.Journal of clinical medicine · 2018Article
- Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized.BMC cancer · 2018Article
- High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation.Scientific reports · 2018Article
- Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma.Oncotarget · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 5 institutions in 2 countries.
Funding
Abstract
Prostate cancer is a common disease in modern, developed societies and has a high incidence and mortality. High-density lipoprotein cholesterol (HDL-C) has recently received much attention as a possible risk marker of prostate cancer development and prognosis. In the present article, we summarized findings from epidemiologic studies of the association between HDL-C and prostate cancer. Low HDL-C level was found to be a risk and prognostic factor of prostate cancer in several epidemiologic studies, although the overall linkage between HDL and prostate cancer has not been definitively established. The mechanisms for this association remain uncertain; however, limited data from experimental studies imply a possible role of HDL in the pathophysiology of prostate cancer. More epidemiologic research, in combination with experimental studies, is needed in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.